⌘K

Login Start Free

Home/Filings/4/0001104659-23-103508

4//SEC Filing

Saik Andrew 4

Accession 0001104659-23-103508

CIK 0001270073other

View on SEC.gov Company Profile

Filed

Sep 24, 8:00 PM ET

Accepted

Sep 25, 4:01 PM ET

Size

4.9 KB

Accession

0001104659-23-103508

Insider Transaction Report

Form 4

Period: 2023-09-21

INTERCEPT PHARMACEUTICALS, INC.ICPT

EVP & Chief Financial Officer

Transactions

Tax Payment
Common Stock
2023-09-21$10.80/sh−908$9,806→ 68,265 total

Footnotes (1)

[F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.

Documents

1 file

4
tm2326871-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

INTERCEPT PHARMACEUTICALS, INC.

CIK 0001270073

Entity typeother

Related Parties

1

filerCIK 0001616284

Filing Metadata

Form type: 4
Filed: Sep 24, 8:00 PM ET
Accepted: Sep 25, 4:01 PM ET
Size: 4.9 KB

View on SEC.gov